CAELYX
CAELYX
Approved
DIN Number
02238389
Drug Class
Human
Market Date
Aug 19, 1998
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238389
AIG Number0110825002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB01 DOXORUBICIN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DOXORUBICIN HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: DOXORUBICIN HYDROCHLORIDE